Results 271 to 280 of about 50,155,014 (329)
PCORnet®: Accelerating Patient-Centered Comparative Clinical Effectiveness Research. [PDF]
Holve E, McTigue K.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Nursing Educators' Perceptions of AI in Research: Risks and Benefits. [PDF]
Mrayyan MT, Al-Omari AK.
europepmc +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Stigma associated with early-onset type 2 diabetes: A secondary qualitative analysis. [PDF]
Hagan J +3 more
europepmc +1 more source

